Development of phenylpropanoid sucrose esters as antidiabetic lead compounds
Alpha-glucosidase inhibitors (AGIs), particularly Acarbose, have received increased attention in the treatment of Type 2 diabetes (T2D) due to their effectiveness in managing postprandial blood glucose and associated macrovascular and microvascular health complications. However, AGIs are commonly pl...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Theses and Dissertations |
| 語言: | English |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://hdl.handle.net/10356/106085 http://hdl.handle.net/10220/47906 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|